RNA Metabolism Flashcards

1
Q

transcribed strand

A

template/antisense/-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

nontranscribed strand

A

nontemplate, coding, +; identical to RNA except RNA will have U’s instead of T’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

requirements for transcription

A

template, all four NTPs, divalent metal ion, no primer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

E. coli RNA polymerase

A

DNA-dependent RNA polymerase; only one type for synthesis of all RNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is RNA not proofread?

A

it is quickly degraded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

RNA polymerase holoenzyme

A

core enzyme + sigma factor; must be in holoenzyme form for polymerization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sigma factor

A

transcription initiation factor that recognizes promoter regions in DNA and facilitates core enzyme to start transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

promoter

A

where RNA polymerase binds on DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

consensus sequence

A

the most common nucleotides at a particular position; practice on slide 25 if forgot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

prokaryote consensus sequences

A

-35 (TTGACA) and -10 (TATA box)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

elongation in prokaryotes

A

sigma factor dissociates, core enzyme proceed along DNA and EF factors bind

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

topoisomerase I (prokaryotes)

A

rewinds DNA behind the transcription bubble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

topoisomerase II (prokaryotes)

A

releases tension ahead of the transcription bubble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

quinolone antibiotics

A

inhibit gyrase, interfering with both DNA replication and transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

polycistronic mRNAs

A

specify more than one protein; only in prokaryotes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

termination in prokaryotes

A

Rho dependent or Rho independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Rho independent

A

palindrome sequence at the end of a gene allows folding of newly transcribed RNA into a hairpin loop –> poly U stretch will pull RNA away from the DNA (not paired strongly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Rho dependent

A

rho protein will bind the RNA and use its ATPase activity to separate DNA-RNA hybrid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Where does transcription occur in eukaryotes?

A

nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mRNA

A

carries genetic information from DNA to ribosome, where it specifies amino acid sequence; synthesized in nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

rRNA

A

structural RNAs; synthesized in nucleolus; 80% of RNA is in cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

tRNA

A

transport amino acids to ribosomes for incorporation into a polypeptide undergoing synthesis; synthesized in nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

miRNA

A

small RNA molecule, which functions in transcriptional and translational regulation of gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

RNA polymerase I

A

transcribes genes in nucleolus; makes 45S for rRNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

45S precursor becomes _

A

5.8, 18, and 28 (major subunit of ribosome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

RNA polymerase III

A

transcribes small stable RNAs, 5S rRNA, tRNAs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

RNA polymerase II

A

transcribes mRNA precursors and miRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

eukaryotic promoter

A

TATA box, located 25-35bp upstream of transcription start site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

general TFs

A

minimal requirements for recognition of promoter; recruitment of RNA polymerase II to promoter, and initiation of transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

sequence specific TFs

A

bind to proximal or distant position –> interact with core factors to modulate transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

pre-initiation complex

A

TFIID binds to DNA –> kinks DNA at each end of TATA box –> other core finders bind

32
Q

TFIID

A

TATA binding protein and TATA associated factors

33
Q

TFIIH

A

helicase activity

34
Q

steps in initiation

A

TFIID binds –> TFIIH has helicase activity to open DNA and phosphorylate TFIIF (RNA polymerase II)

35
Q

xeroderma pigmentosa

A

defective TFIIH; can not perform nucleotide excision repair –> skin extremely sensitive to UV light

36
Q

termination in eukaryotes

A

poly A complex binds to pol II and scans RNA for a polyadenylation site

37
Q

noncoding genes

A

make up 67% of all genes

38
Q

noncoding RNAs

A

housekeeping ncRNAs and regulatory RNAs

39
Q

housekeeping RNAs

A

rRNA, tRNA, snRNA, snoRNA

40
Q

regulatory RNAs

A

short ncRNAs (siRNA, miRNA) and long ncRNAs

41
Q

RNA interference

A

dsRNA enters cell –> Dicer cleaves dsRNA into siRNA duplex –> siRNA recruited by RISC complex –> siRNA unwinds and forms protein-siRNA complex with RISC –> complex binds to target mRNA –> mRNA is cleaved at specific site and then degraded

42
Q

Where does dsRNA come from?

A

RNA viruses, siRNA, endogenous dsRNA, miRNA, added exogenously

43
Q

miRNA regulates gene expression in 3 ways

A
  1. can be incorporated into an RISC and cause degradation
  2. can be incorporated into an RISC and cause translational silencing
  3. can be incorporated into an RNA and cause silencing
44
Q

RNA-induced transcriptional silencing

A

miRNA/siRNA trigger down regulation at specific gene –> histones modify by methylation –> heterochromatin formation

45
Q

Patisiran (RNAi drug)

A

accumulates in livers and targets mutant transthyretin which impairs heart and nerve function

46
Q

possible therapeutical uses of RNAi

A

antiviral therapies (knockdown host receptors), treatment for neurodegenerative diseases (reduce mutant protein levels), cancer (knockdown oncogenes)

47
Q

acridine

A

inhibits all RNA polymerase; anti-septin

**can not be used for cancer treatment because it is too toxic to humans

48
Q

alpha-amanitin

A

specific for polymerase II, very toxic and specific for eukaryotes

49
Q

actinomycin D

A

inhibits all RNA polymerases; antibiotic and anti-cancer agent

50
Q

rifampicin

A

inhibits bacterial RNA polymerase; antibiotic

51
Q

antiseptic

A

used on the skin, contain microorganisms to deter development of bacteria and viruses

52
Q

antibiotics

A

used inside body and only effective against bacterial infections (not viral!)

53
Q

actinomycin D mechanism

A

binds DNA by intercalation causing DNA damage –> blocks DNA and RNA pol movement, inhibiting both transcription and replication

54
Q

How can actinomycin D insert into DNA?

A

it has a conjugated bond and flat structure

55
Q

mitochondrial transcription

A

monomeric RNA polymerase that has 3 promoters; creates polycistronic transcripts

56
Q

mRNA processing (transcription)

A

5’ capping and 3’ poly A tail and splicing

57
Q

5’ cap function

A

regulation of nuclear export, prevention of degradation by exonucleases, promotion of translation, and promotion of 5’ proximal intron excision

58
Q

5’ cap reaction

A

phosphohydrolase cleaves gamma subunit of triphosphate –> guanylyltransferase adds a GTP –> there is now a 5’ - 5’ triphosphate linkage –> 7-methyl guanosine is added

59
Q

polyadenylation

A

CPSF binds the RNA tail –> endonuclease cleaves 10-30 nt downstream of poly A sign, adding an -OH –> polyadenylate polymerase synthesizes poly A tail with adenyl groups coming from ATP

60
Q

polyadenylation functions

A

increases mRNA stability, facilitate exit from nucleus, aids in translation

61
Q

pre-mRNA splicing

A

premature RNA splices out introns to aid in formation of mature RNA

62
Q

conserved splice site sequences

A

upstream splice site (GU), downstream splice site (AG), branch site

63
Q

snRNPs

A

use RNA as guide to find special splicing sequence; snRNA + protein

64
Q

spliceosomes

A

complexes of snRNPs that aid in splicing

65
Q

splicing mechanism

A

snRNP bring the pre-mRNA, bringing sequence of neighboring exons into correct alignment –> 2’ OH group of branch site in the intron attacks the phosphate at the 5’ end of the intron –> creates a lariat structure –> 3’ OH of exon 1 will not bind 5’ at splice acceptor site of exon 2 –> releases intron lariat

66
Q

lupus erythematosus

A

autoantibodies against the snRNPs; causes fatal inflammatory disease

67
Q

ways of alternative splicing

A

use alternative cleavage and polyadenylation site or use different splice sites

68
Q

diseases due to defective splicing

A

familial lipoprotein lipase deficiency, thalassemias, myotonic dystrophy type 1

69
Q

familial lipoprotein lipase deficiency

A

LPL facilitates the removal of lipoproteins from bloodstream –> mutations causes this lipase to be inactive –> triglyceride levels build up leading to problems with pancreas and liver

70
Q

familial lipoprotein lipase deficiency mutation

A

mutation at the acceptor site of intron 6 causes deletion of exon 7 and shifts the reading frame

71
Q

familial beta-thalassemia mutation

A

part of intron 1 remains between exon 1 and exon 2

72
Q

familial beta-thalassemia

A

body makes less hemoglobin, resulting in inefficient oxygenation of body

73
Q

myotonic dystrophy type 1 (DM1) mutation

A

expansion of CTG repeats in the 3’ UTR of DMPK gene –> these transcripts are not retained in the nucleus, triggering cascade of toxic events

74
Q

processing of tRNA

A

5’ and 3’ cleavage, addition of CCA to 3’ end

75
Q

tRNA modification

A

methylation, deamination, reduction

76
Q

mRNA editing

A

changes to specific nucleotides after RNA has been synthesized; rare event

77
Q

example of mRNA editing

A

Apo B-100 to Apo B-48; Apo B-100 is in liver and Apo B-48 is edited to be put in intestine